Taysha Gene Therapies doses patient #2 and provides an update on their clinical trial plans in Canada, US and UK.

So many things about Rett are beyond our control. Accelerating a cure isn’t one of them. Sign up for the Registry now to help drive the development of genetic medicines. #ParentPowered

We are the organization working to cure Rett Syndrome.

You have the power to unlock a world of information, which will entice more Biopharma companies to take on Rett.

Check your RettList today to help us bring #PharmaToTable.

So many things about Rett are beyond our control. Accelerating a cure isn’t one of them. Sign up for the Registry now to help drive the development of genetic medicines. #ParentPowered

We are the organization working to cure Rett Syndrome.

You have the power to unlock a world of information, which will entice more Biopharma companies to take on Rett.

Check your RettList today to help us bring #PharmaToTable.

Donate

Join Us

Taysha Gene Therapies reports on safety and efficacy results for the first patient to receive gene therapy for Rett Syndrome

On September 26 Taysha Gene Therapies shared new information with the community about progress with its clinical trial in Canada for adults with Rett syndrome, and plans to expand to pediatric clinical trials in the US and the UK.

Rett Community Letter

Taysha Press Release

$40M

Take Action

Taysha Doses Patient #2 and Provides Additional Updates